Enterochromaffin (EC) cells are specialized enteroendocrine cells located throughout the gastrointestinal (GI) tract epithelium that serve as the primary source of serotonin (5-hydroxytryptamine or 5-HT) in the peripheral nervous system. These cells play critical roles in gut motility, platelet function, and increasingly recognized gut-brain axis signaling that may influence neurodegenerative disease progression.
| Property | Value |
|---|---|
| Category | Enteroendocrine |
| Location | GI tract epithelium (stomach to colon) |
| Cell Types | Serotonin-producing enteroendocrine |
| Primary Neurotransmitter | Serotonin (5-HT) |
| Key Markers | TPH1, SERT, CHGA, SCG2 |
Enterochromaffin cells are pear-shaped or flask-shaped epithelial cells with basal cytoplasmic processes that extend toward the lamina propria, allowing direct contact with blood vessels and nerve endings. They contain dense-core granules in their cytoplasm that store serotonin.
EC cells synthesize serotonin through the following pathway:
| Protein | Function |
|---|---|
| TPH1 | Rate-limiting enzyme for peripheral serotonin synthesis |
| AADC | Decarboxylates 5-HTP to serotonin |
| SERT | Serotonin reuptake transporter |
| VMAT1 | Vesicular monoamine transporter |
EC cells play a crucial role in regulating gut motility through serotonin release:
Approximately 95% of the body's serotonin is stored in platelets, which acquire it from EC cells through platelet SERT uptake. Platelet-derived serotonin contributes to:
EC cells form a critical link in the gut-brain axis:
EC cell dysfunction may contribute to AD pathogenesis through several mechanisms:
The gut-brain axis connection is particularly relevant in PD:
EC cells are implicated in the gut-brain axis component of mood disorders:
Researchers study EC cells using:
EC cell-derived markers may serve as disease biomarkers:
| Drug Class | Target | Application |
|---|---|---|
| SSRIs | SERT | Depression, IBS |
| 5-HT3 antagonists | 5-HT3R | Chemotherapy-induced nausea |
| 5-HT4 agonists | 5-HT4R | Functional constipation |
The study of Enterochromaffin Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Gershon MD. 5-HT (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14-21.
[2] Mawe GM, Hoffman JM. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473-486.
[3] Yano JM, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264-276.
[4] Banskota S, et al. Serotonin in the gut microbiome and its relevance to neurodegenerative diseases. Neurochem Int. 2019;130:104312.
[5] Clairembault T, et al. Enteric alpha-synuclein burden in the submandibular gland of Parkinson's disease patients. Mov Disord. 2015;30(6):762-766.
[6] Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693(Pt B):128-133.
[7] Mittal R, et al. Serotonin and gut-brain axis in Alzheimer's disease. J Alzheimers Dis. 2021;79(2):661-670.
[8]</sup] Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Support Palliat Care. 2009;3(1):36-41.